Actualités

Shares of semiconductor testing company FormFactor (NASDAQ:FORM) jumped 6.1% in the afternoon session after sentiment improved as peer, Aehr Test Systems, which provides similar semiconductor testing solutions announced it had received a $22 million follow-on production order from a major AI processor customer.

The insider disposed of 40,000 shares, representing a 10% reduction in total holdings.

Shares of Aehr Test Systems (NASDAQ:AEHR) are up roughly 8% in Friday midday, after a fresh Wall Street initiation lit another fire under one of 2026’s most explosive small caps. The move extends a year-to-date advance of 510.7% and pushes the stock through its 52-week high of $133.35. Jefferies Buy Rating and $175 Target Fuel ... Aehr Test Systems Soars Again Friday. Shares Now Up More than 500% On the Year.

AEHR's $22M AI order underscores rising WLBI demand as chip complexity and costs increase, while backlog and bookings point to strong growth.

Aehr Test Systems recently reported a strong fiscal fourth quarter with revenue of US$18.84 million, a return to profitability, and issued very bullish fiscal 2027 revenue guidance supported by record bookings and backlog. The company also disclosed a US$22 million follow-on production order from its lead wafer-level AI processor customer, highlighting growing adoption of its FOX-XP wafer-level burn-in platform for high-volume AI chip manufacturing in Taiwan. We’ll now examine how this large...

Aehr Test Systems (AEHR) is back in focus after a $22 million follow-on production order from its lead wafer-level AI processor customer, along with a recent fiscal Q4 update highlighting a return to profitability. See our latest analysis for Aehr Test Systems. The recent $22 million order and upbeat fiscal Q4 update have coincided with very strong share price momentum for Aehr Test Systems, including an 89.99% 1-month share price return and a very large 1-year total shareholder return. This...

AEHR shares rally on a $22 million follow-on production order. But caution is warranted in chasing the momentum in AEHR stock.

AEHR's 72.2% surge reflects record bookings, a $100.6M backlog and rising AI demand, but its premium valuation raises the stakes.

The insider's sale followed a 484% one-year total return for the stock.

Aehr Test Systems has surged over 400% this year on a dramatic business transformation, but with a price-to-sales ratio that would make most investors flinch and insiders quietly selling into the rally, the question now is whether the momentum has any room left to run.

The semiconductor test company reported another insider disposition amid its stock's 477% one-year return.

Here is how Flex (FLEX) and Aehr Test Systems (AEHR) have performed compared to their sector so far this year.

If you are looking for stocks that are well positioned to maintain their recent uptrend, Aehr Test Systems (AEHR) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Microsoft has posted eight straight quarters of revenue growth, while its smaller peer swung between sharp gains and declines.

The company reported a notable insider sale that reduced their indirect holdings by 21% as the stock surged 470% over the past year.

Both companies are burning cash and trading at steep multiples, but their paths to profitability, and their risks, couldn't be more different.

Aehr Test Systems (AEHR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Aehr Test Systems has delivered a very large 5 year return, yet the stock now screens as expensive on broad valuation checks despite the recent pullback. With the share price at US$76.87, the core issue is whether that long term gain now leaves little room for disappointment. Aehr Test Systems has returned about 12.6x over 5 years, which sets a very high bar for what investors may expect from here. Expectations for continued growth in its testing solutions can support the current valuation,...

The average of price targets set by Wall Street analysts indicates a potential upside of 49.6% in Aehr Test Systems (AEHR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Aehr's record bookings, AI-driven backlog and expanding burn-in portfolio give it the edge over FormFactor for long-term growth.

After losing some value lately, a hammer chart pattern has been formed for Aehr Test Systems (AEHR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

The stock continues to trade as a proxy for AI semiconductor investment, and for good reason.

Aehr Test Systems soared by 27.86 percent on Tuesday to end at $98.91 apiece, as investors resorted to bargain-hunting after falling to the $75 level the previous day, while drawing encouragement from the flurry of AI expansion news that spilled over to industries riding the boom. Threefold Revenue Growth Outlook Despite Higher Losses Aehr Test […]

STT, AEHR and NBIS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 20, 2026.

Here is how Aehr Test Systems (AEHR) and Cisco Systems (CSCO) have performed compared to their sector so far this year.

KTTA, NTRS, YEXT, AEHR and STT have been added to the Zacks Rank #1 (Strong Buy) List on July 20, 2026.

Shares in Aehr Test Systems Inc. (NASDAQ:AEHR) jumped by 11.6 percent week-on-week, as investors increased their exposure after management posted a highly optimistic outlook for fiscal year 2027, thanks to the continued strong demand for semiconductor testing. In an updated report last week, the company said that it is targeting to grow its revenues during […]

Aehr Test Systems beat quarterly estimates and issued FY2027 revenue guidance of $130-$150 million, backed by a $100.6 million backlog and improved gross margins.

The company's burgeoning order growth is a good indicator of investment in AI processors.

Aehr Test Systems gains analyst support as AI demand boosts growth outlook.